Article
Nuclear accumulation of SHIP1 mutants derived from AML patients leads to increased proliferation of leukemic cells.
Cellular signalling - 1 Sept 2018
Nalaskowski Marcus M, Ehm Patrick, Rehbach Christoph, Nelson Nina, Täger Maike, Modest Kathrin, Jücker Manfred
Abstract excerpt
The inositol 5-phosphatase SHIP1 acts as negative regulator of intracellular signaling in myeloid cells and is a tumor suppressor in myeloid leukemogenesis. After relocalization from the cytoplasm to the plasma membrane SHIP1 terminates PI3-kinase mediated signaling processes. Furthermore, SHIP1 is also found in distinct puncta in the cell nucleus and nuclear SHIP1 has a pro-proliferative function. Here we report...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
